Pasar al contenido principal

NUEVAS DIANAS TERAPEUTICAS EN EL SARCOMA DE EWING A TRAVES DEL ESTUDIO DEL PROCESO METASTASICO

PI17/00464

•
Nombre agencia financiadora Instituto de Salud Carlos III
Acrónimo agencia financiadora ISCIII
Programa Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de Investigación en Salud
Año convocatoria 2017
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACION PUBLICA ANDALUZA PARA LA GESTION DE LA INVESTIGACION EN SALUD DE SEVILLA
Centro realización INSTITUTO DE BIOMEDICINA DE SEVILLA - IBIS

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Multidisciplinary consensus on optimising the detection of NTRK gene alterations in tumours

  • Garrido, Pilar|||0000-0002-5899-6125
  • Hladun, Raquel|||0000-0002-3191-1750
  • De Álava, Enrique|||0000-0001-8400-046X
  • Alvarez, Rosa|||0000-0003-0935-8298
  • Bautista, Francisco Jose|||0000-0002-0421-8862
  • López-Ríos, F.
  • Colomer, Ramon|||0000-0002-6393-3444
  • Rojo, F.
The recent identification of rearrangements of neurotrophic tyrosine receptor kinase (NTRK) genes and the development of specific fusion protein inhibitors, such as larotrectinib and entrectinib, have revolutionised the diagnostic and clinical management of patients presenting with tumours with these alterations. Tumours that harbour NTRK fusions are found in both adults and children; and they are either rare tumours with common NTRK fusions that may be diagnostic, or more prevalent tumours with rare NTRK fusions. To assess currently available evidence on this matter, three key Spanish medical societies (the Spanish Society of Medical Oncology (SEOM), the Spanish Society of Pathological Anatomy (SEAP), and the Spanish Society of Paediatric Haematology and Oncology (SEHOP) have brought together a group of experts to develop a consensus document that includes guidelines on the diagnostic, clinical, and therapeutic aspects of NTRK -fusion tumours. This document also discusses the challenges related to the routine detection of these genetic alterations in a mostly public Health Care System.